Harmony Biosciences Holdings, Inc. (HRMY)
33.76
-0.04
(-0.12%)
USD |
NASDAQ |
Nov 13, 16:00
33.85
+0.09
(+0.27%)
After-Hours: 19:59
Harmony Biosciences Holdings Total Assets (Quarterly) : 1.478B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.478B |
| June 30, 2026 | 1.373B |
| March 31, 2026 | 1.272B |
| December 31, 2025 | 1.272B |
| September 30, 2025 | 1.208B |
| June 30, 2025 | 1.108B |
| March 31, 2025 | 1.056B |
| December 31, 2024 | 999.20M |
| September 30, 2024 | 928.14M |
| June 30, 2024 | 858.38M |
| March 31, 2024 | 846.98M |
| December 31, 2023 | 811.45M |
| September 30, 2023 | 777.77M |
| June 30, 2023 | 760.18M |
| Date | Value |
|---|---|
| March 31, 2023 | 715.09M |
| December 31, 2022 | 673.87M |
| September 30, 2022 | 643.46M |
| June 30, 2022 | 505.03M |
| March 31, 2022 | 464.00M |
| December 31, 2021 | 433.44M |
| September 30, 2021 | 391.09M |
| June 30, 2021 | 359.70M |
| March 31, 2021 | 337.25M |
| December 31, 2020 | 427.07M |
| September 30, 2020 | 320.07M |
| June 30, 2020 | 168.82M |
| March 31, 2020 | 163.09M |
| December 31, 2019 | 106.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 204.54B |
| Bristol Myers Squibb Co. | 88.77B |
| Tarsus Pharmaceuticals, Inc. | 505.50M |
| Seaport Therapeutics, Inc. | 417.62M |
| ANI Pharmaceuticals, Inc. | 1.568B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 406.01M |
| Shareholders Equity (Quarterly) | 1.072B |
| Debt to Equity Ratio | 0.2175 |
| Current Ratio | 3.443 |
| Net Debt Paydown Yield | -0.21% |